Role of nitric oxide in the physiopathology of pain

Journal of Pain and Symptom Management

Volumn 14, Issue 4, 1997, Pages 225-254

  Anbar, Michael ^a,b   Gratt, Barton M ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UCLA SCHOOL OF DENTISTRY   (United States)

Author keywords

Analgesics; Chondrocytes; Chronic orofacial pain; Hyperperfusion; Hyperthermia; Macrophages; Nitric oxide; Ostcob lasts; Osteoarthritis; Pain; Rheumatoid arthritis; Temporomandibnlar disorders; Vasodilation

Indexed keywords

NITRIC OXIDE;

ARTICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTHERMIA; PAIN; PATHOPHYSIOLOGY; RHEUMATOID ARTHRITIS; TEMPOROMANDIBULAR JOINT DISORDER; THERMOMETRY; VASODILATATION;

HUMANS; NITRIC OXIDE; PAIN; SKIN TEMPERATURE;

EID: 0030764889     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(97)00178-4     Document Type: Article

References (418)

1. McNeill C. Temporomandibular disorders. In: McNeill C, ed. American Academy of Orofacial Pain Guidelines for classification, assessment and management. Chicago: Quintessence, 1993:11-13, 29, 40-53, 122.
2. Carlsson GE, LeResche L. Epidemiology of temporomandibular disorders. In: Sessle BJ, Bryant PS, Dionne RA, eds. Temporomandibular disorders and related pain, progress in pain research and management, vol 4. Seattle: IASP Press, 1995:211-226.
3. Von Korff M, Dworkin SF, LeResche L, Kruger A. An epidemiologic comparison of pain complaints. Pain 1988;32:173-183.
4. Lipton JA, Ship JA, Larach-Robinson D. Estimated prevalence and distribution of reported orofacial pain in the United States. J Am Dent Assoc 1993;124:115-121.
5. Von Korff M. Health services research and temporomandibular pain. In: Sessle BJ, Bryant PS, Dionne RA, eds. Temporomandibular disorders and related pain, progress in pain research and management, vol 4. Seattle: IASP Press, 1995:227-236.
6. Gratt BM, Sickles EA. Electronic facial thermography: an analysis of asymptomatic adult subjects. J Orofacial Pain 1995;9:255-265.
7. Gratt BM, Sickles EA. Thermographic characterization of the asymptomatic temporomandibular joint. J Orofacial Pain 1993;7:7-14.
8. Uematsu S. Thermographic imaging of cutaneous sensory segment in patients with peripherral nerve injury. Skin temperature stability between sides of the body. J Neurosurg 1985;62:716-720.
9. Gratt BM, Sickles EA, Ross JB, et al. Thermographic assessment of craniomandibular disorders: diagnostic interpretation versus temperature measurement analysis. J Orofacial Pain 1994;8:278-288.
10. Gratt BM, Sickles EA, Wexler CE, Ross JB. Thermographic characterization of an internal derangement of the temporomandibular joint. J Orofacial Pain 1994;8:197-206.
11. Gratt BM, Sickles EA, Wexler CE. Thermographic characterization of osteoarthrosis of the temporomandibular joint. J Orofacial Pain 1993;7: 345-353.
12. Canavan D, Gratt BM. Electronic thermography for the assessment of mild and moderate TMJ dysfunction. Oral Surg Oral Med Oral Pathol 1995;79: 778-786.
13. McBeth SA, Gratt BM. A cross-sectional thermographic assessment of TMJ problems in orthodontic patients. Am J Orthod Dentofacial Orthop 1996;109:481-488.
14. Ketelaer M-C. Thermographic changes seen in traumatic neuraligia following a double-blind somatosensory block. MSc thesis in oral biology, UCLA School of Dentistry, 1995.
15. Ignarro LJ. Nitric oxide as a communication signal in vascular and neuronal cells. In: Lancaster J Jr, ed. Nitric oxide, principles and actions. San Diego: Academic, 1996:111-138.
16. Whittle BJ. Nitric oxide in physiology and pathology. Histochem J 1995;27:727-737.
17. Wink DA, Hanbauer I, Grisham MB, et al. Chemical biology of nitric oxide: regulation and protective and toxic mechanisms. Curr Top Cell Regul 1996;34:159-187.
18. McDonald LJ, Murad F. Nitric oxide and cyclic GMP signaling. Proc Soc Exp Biol Med 1996;211:1-6.
19. Lincoln TM. Cyclic GMP receptor proteins: role in nervous system and other tissues. In: Vincent S, ed. Nitric oxide in the nervous system. San Diego: Academic, 1995:51-82.
20. Murphy S, Grybicki DM, Simmons ML. Glial cells as nitric oxide sources and targets. In: Vincent S, ed. Nitric oxide in the nervous system. San Diego: Academic, 1995:163-190.
21. Rand MJ, Li GG. Nitric oxide in the autonomic and enteric nervous systems. In: Vincent S, ed. Nitric oxide in the nervous system. San Diego: Academic, 1995:227-280.
22. Schuman EM. Nitric oxide signalling, long term potentiation and long term depression. In: Vincent S, ed. Nitric oxide in the nervous system. San Diego: Academic, 1995:125-150.
23. Lancaster J, Stuehr DJ. The intracellular reactions of nitric oxide in the immune system and its enzymatic synthesis. In: Lancaster J Jr, ed. Nitric oxide, principles and actions. San Diego: Academic, 1996:139-176.
24. Levi R, Park KH, Imamura M, et al. Nitric oxide and adrenergic neuromodulation. Adv Pharmacol 1995;34:399-414.
25. Anbar M. Nitric oxide: a synchronizing chemical messenger. Experientia 1995;51:545-550.
26. Ignarro LJ. Nitric oxide-mediated vasorelaxation. Thromb Haemost 1993;70:148-151.
27. Wang Y, Mardsen PA. Nitric oxide synthases: gene structure and regulation. Adv Pharmacol 1995;34:71-90.
28. Fukuto JM, Mayer B. The enzymology of nitric oxide synthase. In: Feelisch M, Stamler JS, eds. Methods in nitric oxide research. Chichester: John Wiley and Sons, 1996:147-160.
29. Michel T, Xie QW, Nathan C. Molecular biological analysis of nitric oxide synthases. In: Feelisch M, Stamler JS, eds. Methods in nitric oxide research. Chichester: John Wiley and Sons, 1996:161-175.
30. Lewis DA, Rud KS, Miller VM. Cofactors of constitutive nitric oxide synthase and endothelium-dependent relaxations in canine femoral veins. J Cardiovasc Pharmacol 1993;22:443-448.
31. Gao Y, hou H, aj JU. Endothelium-derived nitric oxide plays a larger role in pulmonary veins than in arteries of newborn lambs. Circ Res 1995;76:559-565.
32. Buga GM, gnarro LJ. Electrical field stimulation causes endothelium-dependent and nitric oxide-mediated relaxation of pulmonary artery. Am J Physiol 1992;262:H973-979.
33. 2+ concentration and catecholamine release in bovine adrenal chromaffin cells. Jpn J Pharmacol 1994;65:73-77.
34. Buga GM, Griscavage JM, Rogers NE, Ignarro LJ. Negative feedback regulation of endothelial cell function by nitric oxide. Circ Res 1993;73:808-812.
35. Griscavage JM, Hobbs AJ, Ignarro LJ. Negative modulation of nitric oxide synthase by nitric oxide and nitroso compounds. Adv Pharmacol 1995;34: 215-234.
36. Persechini A, McMillan K, Leakey P. Activation of myosin light chain kinase and nitric oxide synthase activities by calmodulin fragments. J Biol Chem 1994;269:16148-16154.
37. Bredt DS. Targeting nitric oxide to its targets. Proc Soc Exp Biol Med 1996;211:41-48.
38. Albina JE, Reichner JS. Nitric oxide in inflammation and immunity. New Horiz 1995;3:46-64.
39. Szabo C, Thiemermann C. Regulation of the expression of the inducible isoform of nitric oxide synthase. Adv Pharmacol 1995;34:113-154.
40. Wong JM, Billiar TR. Regulation and function of inducible nitric oxide synthase during sepsis and acute inflammation. Adv Pharmacol 1995;34:155-170.
41. Forstermann U, Kleinert H. Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn Schmiedebergs Arch Pharmacol 1995;352:351-364.
42. Murrell GAC, Dolan MM, Jang D, et al. Nitric oxide - an important articular free radical. J Bone Joint Surg 1996;78A:265-274.
43. Salzman AL, Menconi MJ, Unno N, et al. Nitric oxide dilates tight junctions and depletes ATP in cultured Caco-2BBe intestinal epithelial monolayers. Am J Physiol 1995;268:G361-373.
44. Stadler J, Schmalix WA, Doehmer J. Inhibition of biotransformation by nitric oxide (NO) overproduction and toxic consequences. Toxicol Lett 1995;82-3:215-219.
45. Hurst RD, Chowdhury R, Clark JB. Investiga-tions into the mechanism of action of a novel nitric oxide generator on cellular respiration. J Neurochem 1996;67:1200-1207.
46. Anbar M. Hyperthermia of the cancerous breast - analysis of mechanism. Cancer Lett 1994;84:23-29.
47. Anbar M. Thermological implication of vasodilation mediated by nitric oxide. Thermologie Osterreich 1995;5:15-27.
48. Chenitz JE. Rheumatoid arthritis and its implications in temporomandibular disorders. Cranio 1992;10:59-69.
49. Farrell AJ, Blake DR, Palmer RM, Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992;51:1219-1222.
50. Ralston SH, Todd D, Helfrich M, et al. Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology 1994;135:330-336.
51. Kaur H, Halliwell B. Evidence for nitric oxidemediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett 1994;350:9-12.
52. Connor JR, Manning PT, Settle SL, et al. Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur J Pharmacol 1995;273:15-24.
53. Houri JM, O'Sullivan FX. Animal models in rheumatoid arthritis. Curr Opin Rheumatol 1995;7:201-205.
54. Grabowski PS, England AJ, Dykhuizen R, et al. Elevated nitric oxide production in rheumatoid arthritis - detection using the fasting urinary nitrate/creatinine ratio. Arthritis Rheum 1996;39:643-647.
55. Grabowski PS, Macpherson H, Ralston SH. Nitric oxide production in cells derived from the human joint. Br J Rheumatol 1996;35:207-212.
56. Ueki Y, Miyake S, Tominaga Y, Eguchi K. Increased nitric oxide levels in patients with rheumatoid arthritis. J Rheumatol 1996;23:230-236.
57. Scher DM, Stolerman E, DiCesare PE. Biologic markers of arthritis. Am J Orthoped 1996;25:263-272.
58. Cosh JA, Ring EFJ. Techniques of heat detection used in the assessment of rheumatic diseases. J Radiol Electrol Med Nucl 1967;48:84-89.
59. Collins AJ, Ring F, Bacon PA, Brookshaw JD. Thermography and radiology complimentary methods for the study of inflammatory diseases. Clin Radiol 1976;27:237-243.
60. Devereaux MD, Parr GR, Thomas DP, Hazleman BL. Disease activity indexes in rheumatoid arthritis; a prospective, comparative study with thermography. Ann Rheum Dis 1985;44:434-437.
61. Schattenkirchner M. Diagnostic methods for evaluation of activity in inflammatory rheumatic disease. Scand J Rheumatol 1987;65(suppl):63-70.
62. Fioravanti A, Franci A, Gelli R, et al. Evaluation of the efficacy of intra-articular administration of somatostatin in rheumatoid arthritis. Clin Ter 1993; 142:453-457.
63. Devereaux MD, Parr GR, Lachmann SM, et al. Thermographic diagnosis in athletes with patellofemoral arthralgia. J Bone Joint Surg 1986;68:42-44.
64. Anbar M. Dynamic area telethermometry - a new field in clinical thermology. Part I. Med Electron 1994;146:62-73.
65. Anbar M. Dynamic area telethermometry - a new field in clinical thermology. Part II. Med Electron 1994;147:73-85.
66. Black CM, Clark RP, Darton K, et al. A pyroelectric thermal imaging system for use in medical diagnosis. J Biomed Eng 1990;12:281-286.
67. Biundo JJ Jr, Torres-Ramos FM. Rehabilitation and biomechanics. Curr Opin Rheumatol 1991;3:291-299.
68. Will RK, Ring EF, Clarke AK, Maddison PJ. Infrared thermography: what is its place in rheumatology in the 1990s? Br J Rheumatol 1992;31:337-344.
69. Hall J, Clarke AK, Elvins DM, Ring EF. Low level laser therapy is ineffective in the management of rheumatoid arthritic finger joints. Br J Rheumatol 1994;33:142-147.
70. Fioravanti A, Govoni M, La Montagna G, et al. Somatostatin 14 and joint inflammation: evidence for intraarticular efficacy of prolonged administration in rheumatoid arthritis. Drugs Exp Clin Res 1995;21:97-103.
71. Palmer RM, Hickery MS, Charles IG, et al. Induction of nitric oxide synthase in human chondrocytes. Biochem Biophys Res Commun 1993;193:398-405.
72. Beckmann JS, Ye YZ, Anderson PG, et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem 1994;375:81-88.
73. Crow JP, Beckman JS. Reactions between nitric oxide, superoxide, and peroxynitrate: Footprints of peroxynitrate in vivo. Adv Pharmacol 1995;34:17-43.
74. Ischiropoulos H, al-Mehdi AB. Peroxynitritemediated oxidative protein modifications. FEBS Lett 1995;364:279-282.
75. Stichtenoth DO, Fauler J, Zeidler H, Frolich JC. Urinary nitrate excretion is increased in patients with rheumatoid arthritis and reduced by prednisolone. Ann Rheum Dis 1995;54:820-824.
76. Renoux M, Hilliquin P, Galoppin L, et al. Cellular activation products in osteoarthritis synovial fluid. Int J Clin Pharmacol Res 1995;15:135-138.
77. Schellhas KP, Piper MA, Omlie MR. Facial skeleton remodeling due to temporomandibular joint degeneration: an imaging study of 100 patients. Cranio 1992;10:248-259.
78. Luder HU, Schroeder HE. Light and electron microscopic morphology of the temporomandibular joint in growing and mature crab-eating monkeys (Macaca fascicularis): the condylar calcified cartilage. Anat Embryology 1992;185:189-199.
79. Piette E. Anatomy of the human temporomandibular joint. An updated comprehensive review. Acta Stomatol Belg 1993;90:103-127.
80. Sato H, Fujii T, Yamada N, Kitamori H. Temporomandibular joint osteoarthritis: a comparative clinical and tomographic study pre-and post-treatment. J Oral Rehabil 1994;21:383-395.
81. Kang JD, Georgescu HI, Mcintyrelarkin L, et al. Herniated cervical intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine 1995;20:2373-2378.
82. Kang JD, Georgescu HI, Mcintyrelarkin L, et al. Herniated cervical intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine 1996;21:271-277.
83. Asahara H, Yokoi I, Tamada T, et al. Increased cerebrospinal fluid nitrite and nitrate levels in patients with lumbar spondylosis. Res Commun Mol Pathol Pharmacol 1996;91:77-83.
84. Evans DM, Ralston SH. Nitric oxide and bone. J Bone Miner Res 1996;11:300-305.
85. Zaidi M, Alam AS, Bax BE, et al. Role of the endothelial cell in osteoclast control: new perspectives. Bone 1993;14:97-102.
86. Sunyer T, Rothe L, Jiang XS, et al. Proinflammatory agents, IL-8 and IL-10, upregulate inducible nitric oxide synthase expression and nitric oxide production in avian osteoclast-like cells. J Cell Biochem 1996;60:469-483.
87. MacIntyre I, Zaidi M, Alam AS, et al. Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP. Proc Natl Acad Sci USA 1991;88:2936-2940.
88. Hukkanen M, Hughes FJ, Buttery LDK, et al. Cytokine-stimulated expression of inducible nitric oxide synthase by mouse, rat, and human osteoblast-like cells and its functional role in osteoblast metabolic activity. Endocrinology 1995;136:5445-5453.
89. De Grooth R, Mieremet RH, Kawilarang-De Haas EW, Nijweide PJ. Murine macrophage precursor cell lines are unable to differentiate into osteoclasts: a possible implication for osteoclast ontogeny. Int J Exp Pathol 1994;75:265-275.
90. Martin TJ, Ng KW. Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity. J Cell Biochem 1994;56:357-366.
91. Horowitz SM, Rapuano BP, Lane JM, Burstein AH. The interaction of the macrophage and the osteoblast in the pathophysiology of aseptic loosening of joint replacements. Calcif Tissue Int 1994;54:320-324.
92. Takaishi T, Matsui T, Tsukamoto T, et al. TGF-beta-induced macrophage colony-stimulating factor gene expression in various mesenchymal cell lines. Am J Physiol 1994;267:C25-31.
93. Weinberg JB, Misukonis MA, Shami Pf, et al. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS) - analysis of inos mrna, inos protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 1995;86:1184-1195.
94. Schoedon G, Schneemann M, Walter R, et al. Nitric oxide and infection: another view. Clin Infect Dis 1995;21(suppl 2) :S152-157.
95. Merryman PF, Clancy RM, He XY, Abramson SB. Modulation of human T cell responses by nitric oxide and its derivative, S-nitrosoglutathione. Arthritis Rheum 1993;36:1414-1422.
96. Hoffman RA, Langrehr JM, Simmons RL. Role of nitric oxide in allograph rejection. In: Lancaster J Jr, ed. Nitric oxide, principles and actions. San Diego: Academic, 1996:237-257.
97. Denham S, Rowland IJ. Inhibition of the reactive proliferation of lymphocytes by activated macrophages: the role of nitric oxide. Clin Exp Immunol 1992;87:157-162.
98. Blackburn WD. Management of osteoarthritis and rheumatoid arthritis - prospects and possibilities. Am J Med 1996;100(suppl 2A):S24-S30.
99. Watkins LR, Maier SF, Goehler LE. Immune activation - the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 1995;63:289-302.
100. Sharma JN, Buchanan WW. Pathogenic responses of bradykinin system in chronic inflammatory rheumatoid disease. Exp Tox Pathol 1994;46:421-433.
101. Walker K, Perkins M, Dray A. Kinins and kinin receptors in the nervous system. Neurochem Int 1995;26:1-16.
102. Ferreira SH. The role of interleukins and nitric oxide in the mediation of inflammatory pain and its control by peripheral analgesics. Drugs 1993;46(suppl 1):1-9.
103. Bauer MB, Murphy S, Gebhart GF. Stimulation of cyclic GMP production via a nitrosyl factor in sensory neuronal cultures by algesic or inflammatory agents. J Neurochem 1995;65:363-372.
104. Marianipedroso SR, Bizeto L, Antunes E, el al. Dissimilarity between prostaglandin E(1) and nitric oxide donors as potentiators of plasma exudation in the rabbit skin in vivo. Prostaglandins Leukot Essent Fatty Acids 1995;52:399-402.
105. Teixeira MM, Williams TJ, Hellewell PG. Role of prostaglandins and nitric oxide in acute inflammatory reactions in guinea-pig skin. Br J Pharmacol 1993;110:1515-1521.
106. Oyanagui Y, Sato S. Opposite effect of superoxide dismutase, L-arginine analogues, methylene blue and desferal: suppression of histamine-induced and stimulation of serotonin-induced paw edema in mice. Biol Signals 1993;2:37-44.
107. Holzer P, Jocic M, Peskar BA. Mediation by prostaglandins of the nitric oxide-induced neurogenic vasodilatation in rat skin. Br J Pharmacol 1995;116:2365-2370.
108. Muhl H, Pfeilschifter J. Tetrahydrobiopterin is a limiting factor of nitric oxide generation in interleukin 1 beta-stimulated rat glomerular mesangial cells. Kidney Int 1994;46:1302-1306.
109. Vandijk APM, Keuskamp ZJ, Wilson JHP, Zijlstra FJ. Sequential release of cytokines, lipid mediators and nitric oxide in experimental colitis. Mediators Inflamm 1995;4:186-190.
110. Kolios G, Brown Z, Robson RL, et al. Inducible nitric oxide synthase activity and expression in a human colonie epithelial cell line, HT-29. Br J Pharmacol 1995;116:2866-2872.
111. Kitade H, Sakitani K, Inoue K, et al. Interleukin 1 beta markedly stimulates nitric oxide formation in the absence of other cytokines or lipopolysaccharide in primary cultured rat hepatocytes but not in Kupffer cells. Hepatology 1996;23:797-802.
112. Eberhardt W, Kunz D, Hummel R, Pfeilschifter J. Molecular cloning of the rat inducible nitric oxide synthase gene promoter. Biochem Biophys Res Commun 1996;223:752-756.
113. Tetsuka T, Baier LD, Morrison AR. Antioxidants inhibit interleukin-1-induced cyclooxygenase and nitric-oxide synthase expression in rat mesangial cells. Evidence for post-transcriptional regulation. J Biol Chem 1996;271:11689-11693.
114. Brunetti L, Volpe AR, Ragazzoni E, et al. Interleukin-1 beta specifically stimulates nitric oxide production in the hypothalamus. Life Sci 1996;58:PL373-377.
115. Ikeda U, Kanbe T, Shimada K. Adrenomedullin increases inducible nitric oxide synthase in rat vascular smooth muscle cells stimulated with interleukin-1. Hypertension 1996;27:1240-1244.
116. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996:87:2095-2147.
117. Farivar RS, Chobanian AV, Brecher P. Salicylate or aspirin inhibits the induction of the inducible nitric oxide synthase in rat cardiac fibroblasts. Circ Res 1996;78:759-768.
118. Sirsjo A, Karlsson M, Gidlof A, et al. Increased expression of inducible nitric oxide synthase in psoriatic skin and cytokine-stimulated cultured keratinocytes. Br J Dermatol 1996;134:643-648.
119. Kolyada AY, Savikovsky N, Madias NE. Tran-scriptional regulation of the human iNOS gene in vascular-smooth-muscle cells and macrophages: evidence for tissue specificity. Biochem Biophys Res Commun 1996;220:600-605.
120. Durante W, Liao L, Iftikhar I, et al. Differential regulation of 1-arginine transport and nitric oxide production by vascular smooth muscle and endothelium. Circ Res 1996;78:1075-1082.
121. Rivier C. Blockade of nitric oxide formation augments adrenocorticotropin released by blood-borne interleukin-1 beta: role of vasopressin, prostaglandins, and alpha 1-adrenergic receptors. Endocrinology 1995;136:3597-3603.
122. Palmgren T, Gronblad M, Virri J, et al. Immunohistochemical demonstration of sensory and autonomic nerve terminals in herniated lumbar disc tissue. Spine 1996;21:1301-1306.
123. Zhang RX, Mi ZP, Qiao JT. Changes of spinal substance P, calcitonin gene-related peptide, somatostatin, Met-enkephalin and neurotensin in rats in response to formalin-induced pain. Regul Pept 1994;51:25-32.
124. Duggan AW, Furmidge LJ. Probing the brain and spinal cord with neuropeptides in pathways related to pain and other functions. Front Neuroendocrinol 1994;15:275-300.
125. Abbadie C, Brown JL, Mantyh PW, Basbaum AI. Spinal cord substance P receptor immunoreactivity increases in both inflammatory and nerve injury models of persistent pain. Neuroscience 1996;70:201-209.
126. Deal CL, Schnitzer TJ, Lipstein E, et al. Treatment of arthritis with topical capsaicin: a double-blind trial. Clin Ther 1991;13:383-395.
127. Menkes CJ, Renoux M, Laoussadi S, et al. Substance P levels in the synovium and synovial fluid from patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 1993;20:714-717.
128. Watkins LR, Wiertelak EP, Furness LE, Maier SF. Illness-induced hyperalgesia is mediated by spinal neuropeptides and excitatory amino acids. Brain Res 1994;664:17-24.
129. Moore AR, Willoughby DA. Hyaluronan as a drug delivery system for diclofenac - a hypothesis for mode of action. Int J Tissue React 1995;17:153-156.
130. Bjorkman R, Hallman KM, Hedner J, et al. Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P. Pain 1994;57:259-264.
131. Coderre TJ, Yashpal K. Intracellular messengers contributing to persistent nociception and hyperalgesia induced by L-glutamate and substance P in the rat formalin pain model. Eur J Neurosci 1994;6:1328-1334.
132. Ralevic V, Khalil Z, Helme RD, Dusting GJ. Role of nitric oxide in the actions of substance P and other mediators of inflammation in rat skin microvasculature. Eur J Pharmacol 1995;284:231-239.
133. Radhakrishnan V, Yashpal K, Hui-Chan CW, Henry JL. Implication of a nitric oxide synthase mechanism in the action of substance P: L-NAME blocks thermal hyperalgesia induced by endogenous and exogenous substance P in the rat. Eur J Neurosci 1995;7:1920-1925.
134. Harris ED. The rationale for combination therapy of rheumatoid arthritis based on pathophysiology. J Rheumatol 1996;23(suppl 44):2-4.
135. Mauel J, Ransijn A, Corradin SB, Buchmullerrouiller Y. Effect of PGE(2) and of agents that raise camp levels on macrophage activation induced by IFN-gamma and TNF-alpha. J Leukoc Biol 1995;58:217-224.
136. Deakin AM, Payne AN, Whittle BJR. The modulation of IL-6 and TNF-alpha release by nitric oxide following stimulation of J774 cells with LPS and IFN-gamma. Cytokine 1995;7:408-416.
137. Harbrecht BG, Mcclure EA, Simmons RL, Billiar TR. Prostanoids inhibit kupffer cell nitric oxide synthesis. J Surg Res 1995;58:625-629.
138. Sautebin L, Ialenti A, Ianaro A, Di Rosa M. Endogenous nitric oxide increases prostaglandin biosynthesis in carrageenin rat paw oedema. Eur J Pharmacol 1995;286:219-222.
139. Mollace V, Colasanti M, Rodino P, et al. NMDA-dependent prostaglandin E(2) release by human cultured astroglial cells is driven by nitric oxide. Biochem Biophys Res Commun 1995;215:793-799.
140. Molinaholgado F, Lledo A, Guaza C. Evidence for cyclooxygenase activation by nitric oxide in astrocytes. Glia 1995;15:167-172.
141. Wilson KT, Vaandrager AB, De Vente J, et al. Production and localization of cGMP and PGE2 in nitroprusside-stimulated rat colonic ion transport. Am J Physiol 1996;270:C832-C840.
142. Dong YL, Yallampalli C. Interaction between nitric oxide and prostaglandin E2 pathways in pregnant rat uteri. Am J Physiol 1996;270:E471-E476.
143. Goldsmith PC, Leslie TA, Haves NA, et al. Inhibitors of nitric oxide synthase in human skin. J Invest Dermatol 1996;106:113-118.
144. Yeh JL, Whitney EG, Lamb S, Brophy CM. Nitric oxide is an autocrine feedback inhibitor of vascular smooth muscle contraction. Surgery 1996;119:104-109.
145. Gaboury JP, Niu XF, Kubes P. Nitric oxide inhibits numerous features of mast cell-induced inflammation. Circulation 1996;93:318-326.
146. Oyanagui Y, Sato S. Histamine paw edema of mice was increased and became H2-antagonist sensitive by co-injection of nitric oxide forming agents, but serotonin paw edema was decreased. Life Sci 1993;52:159-164.
147. Francischi JN, Dias MF, Rocha OA, et al. Pharmacological characterization of Sephadex-induced oedema in rat paws: predominant role of serotonin and platelet-activating factor. Int Arch Allergy Appl Immunol 1996;109:398-406.
148. Bruning TA, van Zwieten PA, Blauw GJ, Chang PC. No functional involvement of 5-hydroxy-tryptamine 1A receptors in nitric oxide-dependent dilatation caused by serotonin in the human forearm vascular bed. J Cardiovasc Pharmacol 1994;24:454-461.
149. Stroes ESG, Koomans HA, Debruin TWA, Rabelink TJ. Vascular function in the forearm of hypercholesterolaemic patients off and on lipidlowering medication. Lancet 1995;346:467-471.
150. Stroes ES, Joles JA, Chang PC, et al. Impaired endothelial function in patients with nephrotic range proteinuria. Kidney Int 1995;48:544-550.
151. Ramadan NM, Gilkey SJ, Mitchell M, et al. Postangiography headache. Headache 1995;35:21-24.
152. Briejer MR, Akkermans LM, Schuurkes JA. Interactions of serotonin with multiple receptors and neurotransmitters in the guinea-pig isolated colon. Arch Int Pharmacodyn Ther 1995;329:121-133.
153. Kuhn DM, Arthur RE Jr. Inactivation of brain tryptophan hydroxylase by nitric oxide. J Neurochem 1996;67:1072-1077.
154. Winther K, Oxholm P, Sengelov H. Effect of auranofin on human platelet aggregation, release of serotonin, and cyclic-AMP formation. Inflammation 1988;12:107-112.
155. Endresen GK. Evidence for activation of platelets in the synuvial fluid from patients with rheumatoid arthritis. Rheumatol Int 1989;9:19-24.
156. Iversen HK. Experimental headache in humans. Cephalalgia 1995;15:281-287.
157. Lassen LH, Thomsen LL, Olesen J. Histamine induces migraine via the H-1-receptorsupport for the NO hypothesis of migraine. Neuroreport 1995;6:1475-1479.
158. Dear JW, Scadding GK, Foreman JC. Reduction by N-G-nitro-1-arginine methyl ester (1-NAME) of antigen-induced nasal airway plasma extravasation in human subjects in vivo. Br J Pharmacol 1995;116:1720-1722.
159. Meijer F, Ruijter JM, Vandelft JL, Vanhaeringen NJ. Nitric oxide induces vascular permeability changes in the guinea pig conjunctiva. Eur J Pharmacol 1995;284:61-67.
160. Feldman MJ, Morris GP, Dinda PK, Paterson WG. Mast cells mediate acid-induced augmentation of opossum esophageal blood flow via histamine and nitric oxide. Gastroenterology 1996;110:121-128.
161. Izumi H, Makino Y, Shirakawa K, Garfield RE. Role of nitric oxide on vasorelaxation in human umbilical artery. Am J Obstet Gynecol 1995;172:1477-1484.
162. Kawai Y, Ohhashi T. Histamine H-2 receptormediated endothelium-dependent relaxation in canine spinal artery. Jpn J Physiol 1995;45:607-618.
163. Nakahara T, Ishii K, Iwamoto KI, Nakayama K. Differential significance of nitric oxide in hypotensive mechanisms of acetylcholine and histamine in dogs. Res Commun Mol Pathol Pharmacol 1995;89: 77-84.
164. Laight DW, Woodward B, Waterfall JF. Renal vasodilation to histamine in vitro: roles of nitric oxide, cyclo-oxygenase products and H2 receptors. Inflam Res 1995;44:116-120.
165. Zygmunt PM, Ryman T, Hogestatt ED. Regional differences in endothelium-dependent relaxation in the rat: contribution of nitric oxide and nitric oxide-independent mechanisms. Acta Physiol Scand 1995;155:257-266.
166. Beyak M, Vanner S. Histamine H1 and H3 vasodilator mechanisms in the guinea pig ileum. Gastroenterology 1995;108:712-718.
167. Oyanagui Y, Sato S. Histamine paw edema of mice was increased and became H2-antagonist sensitive by co-injection of nitric oxide forming agents, but serotonin paw edema was decreased. Life Sci 1993;52:PL159-64.
168. Noel AA, Fallek SR, Hobson RW, Duran WN. Inhibition of nitric oxide synthase attenuates primed microvascular permeability in the in vivo microcirculation. J Vasc Surg 1995;22:661-670.
169. Ziganshina LE, Ziganshin AU, Hoyle CHV, Burnstock G. Acute paw oedema formation induced by ATP - re-evaluation of the mechanisms involved. Inflam Res 1996;45:96-102.
170. Manfredi AA, Rovere P, Ferrarini M, et al. Tuberculosis, sarcoidosis and Hodgkins disease -theme with variations. Fund Clin Immunol 1995;3:147-152.
171. Preiser JC, Reper P, Vlasselaer K, et al. Nitric oxide production is increased in patients after burn injury. J Trauma Inj Infect Crit Care 1996;40:368-371.
172. Benvenuti C, Bories PN, Loisance D. Increased serum nitrate concentration in cardiac transplant patients - a marker for acute allograft cellular rejection. Transplantation 1996;61:745-749.
173. Eisenstein TK, Huang D, Meissler JJ Jr, al-Ramadi B. Macrophage nitric oxide mediates immunosuppression in infectious inflammation. Immunobiol 1994;191:493-502.
174. Green SJ, Scheller LF, Marletta MA, et al. Nitric oxide: cytokine-regulation of nitric oxide in host resistance to intracellular pathogens. Immunol Lett 1994;43:87-94.
175. Nicholson S, Bonecinialmeida MDG, Silva JRL, et al. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med 1996;183:2293-2302.
176. Tomioka H, Sato K, Maw WW, Saito H. The role of tumor necrosis factor, interferon-gamma, transforming growth factor-beta, and nitric oxide in the expression of immunosuppressive functions of splenic macrophages induced by mycobacterium avium complex infection. J Leukoc Biol 1995;58:704-712.
177. Shapiro KB, Hotchkiss JH. Induction of nitric oxide synthesis in murine macrophages by helicobacter pylori. Cancer Lett 1996;102:49-56.
178. Sirsjo A, Karlsson M, Gidlof A, et al. Increased expression of inducible nitric oxide synthase in psoriatic skin and cytokine-stimulated cultured keratinocytes. Br J Dermatol 1996;134:643-648.
179. Ippolito F, Di Carlo A, Carducci M, et al. Cyclosporin A and psoriasis: a thermographic study. Acta Derm Venereol Suppl (Stockh) 1989;146:155-158.
180. Goldman D, Cho Y, Zhao ML, et al. Expression of inducible nitric oxide synthase in rat pulmonary cryptococcus neoformans granulomas. Am J Pathol 1996;148:1275-1282.
181. Kaplan SS, Lancaster JR, Basford RE, Simmons RL. Effect of nitric oxide on staphylococcal killing and interactive effect with superoxide. Infect Immun 1996;64:69-76.
182. James SL. Role of nitric oxide in parasitic infections. Microbiol Rev 1995;59:533-581.
183. Stenger S, Donhauser N, Thuring H, et al. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J Exp Med 1996;183:1501-1514.
184. Silva JS, Vespa GNR, Cardoso MAG, et al. Tumor necrosis factor alpha mediates resistance to typanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect Immun 1995;63:4862-4867.
185. Jacobs P, Radzioch D, Stevenson MM. In vivo regulation of nitric oxide production by tumor necrosis factor alpha and gamma interferon, but not by interleukin-4, during blood stage malaria in mice. Infect Immun 1996;64:44-49.
186. Igietseme JU. The molecular mechanism of T-cell control of chlamydia in mice - role of nitric oxide. Immunology 1996;87:1-8.
187. Igietseme JU. Molecular mechanism of T-cell control of chlamydia in mice - role of nitric oxide in vivo. Immunology 1996;88:1-5.
188. Degroote MA, Testerman T, Xu YS, et al. Homocysteine antagonism of nitric oxide-related cytostasis in salmonella typhimurium. Science 1996; 272:414-417.
189. Shellito JE, Kolls JK, Olariu R, Beck JM. Nitric oxide and host defense against pneumocystis carinii infection in a mouse model. J Infect Dis 1996;173:432-439.
190. Bevan JA. Flow regulation of vascular tone. Its sensitivity to changes in sodium and calcium. Hypertension 1993;22:273-281.
191. Korenaga R, Ando J, Tsuboi H, et al. Laminar flow stimulates ATP-and shear stress-dependent nitric oxide production in cultured bovine endothelial cells. Biochem Biophys Res Commun 1994;198:213-219.
192. Awolesi MA, Widmann MD, Sessa WC, Sumpio BE. Cyclic strain increases endothelial nitric oxide synthase activity. Surgery 1994;116:439-444.
193. Noris M, Morigi M, Donadelli R, et al. Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ Res 1995;76:536-543.
194. Hishikawa K, Nakaki T, Marumo T, et al. Pressure enhances endothelin-1 release from cultured human endothelial cells. Hypertension 1995;25:449-452.
195. Rubin CT, Donahue HJ, Rubin JE, McLeod KJ. Optimization of electric field parameters for the control of bone remodeling: exploitation of an indigenous mechanism for the prevention of osteopenia. J Bone Miner Res 1993;8(suppl 2):S573-581.
196. Fleming I, Busse R. Control and consequences of endothelial nitric oxide formation. Adv Pharmacol 1995;34:187-206.
197. Abu-Soud HM, Feldman PL, Clark P, Stuehr DJ. Electron transfer in the nitric-oxide synthases. Characterization of L-arginine analogs that block heme iron reduction. J Biol Chem 1994;269:32318-32326.
198. Campos KL, Giovanelli J, Kaufman S. Characteristics of the nitric oxide synthase-catalyzed conversion of arginine to N-hydroxyarginine, the first oxygenation step in the enzymic synthesis of nitric oxide. J Biol Chem 1995;270:1721-1728.
199. Hernandez M, Prieto D, Orensanz LM, et al. Nitric oxide is involved in the non-adrenergic, non-cholinergic inhibitory neurotransmission of the pig intravesical ureter. Neurosci Lett 1995;186:33-36.
200. Jing L, Inoue R, Tashiro K, et al. Role of nitric oxide in non-adrenergic, non-cholinergic relaxation and modulation of excitatory neuroeffector transmission in the cat airway. J Physiol 1995;483:225-237.
201. Lippe IT, Stabentheiner A, Holzer P. Participation of nitric oxide in the mustard oil-induced neurogenic inflammation of the rat paw skin. Eur J Pharmacol 1993;232:113-120.
202. Mathison R, Davison JS. Regulation of jejunal arterioles by capsaicin-sensitive nerves in Nippostrongylus brasiliensis-sensitized rats. J Pharmacol Exp Ther 1995;273:337-343.
203. Amin AR, DiCesare PE, Vyas P, et al. The expression and regulation of nitric oxide synthase in human osteoarthtitis-affected chondrocytes: evidence for up-regulated neuronal nitric oxide synthase. J Exp Med 1995;182:2097-2102.
204. Saumet JL, Degoute CS, Saumet M. Abraham P. The effect of nerve blockade on forearm and finger skin blood flow during body heating and cooling. Int J Microcirc Clin Exp 1992;11:231-240.
205. Varner PD, Beckman JS. Nitric oxide toxicity in neuronal injury and degradation. In: Vincent S, ed. Nitric oxide in the nervous system. San Diego: Academic, 1995:191-206.
206. Oyanagui Y. Immunosuppressants and TGF-beta 1 accelerated and prolonged the nitric oxide/ oxyradicals-dependent suppression by dexamethasone in paw edema of mice. Life Sci 1996;58:PL287-294.
207. Moilanen E, Vapaatalo H. Nitric oxide in inflammation and immune response. Ann Med 1995;27:359-367.
208. Liew FY. Nitric oxide in infectious and autoimmune diseases. Ciba Found Symp 1995;195:234-244.
209. Lyons CR. The role of nitric oxide in inflammation. Adv Immunol 1995;60:323-371.
210. Clancy RM, Abramson SB. Nitric oxide: a novel mediator of inflammation. Proc Soc Exp Biol Med 1995;210:93-101.
211. Cattell V, Jansen A. Inducible nitric oxide synthase in inflammation. Histochem J 1995;27:777-784.
212. Michaelis M, Habler HJ, Janig W. Silent afferents - a separate class of primary afferents. Clin Exp Pharmacol Physiol 1996;23:99-105.
213. Qian Y, Chao DS, Santillano DR, et al. cGMP-dependent protein kinase in dorsal root ganglion: relationship with nitric oxide synthase and nociceptive neurons. J Neurosci 1996;16:3130-3138.
214. Onaka M, Minami T, Nishihara I, Ito S. Involvement of glutamate receptors in strychnineand bicuculline-induced allodynia in conscious mice. Anesthesiology 1996;84:1215-1222.
215. Kakizaki H, de Groat WC. Role of spinal nitric oxide in the facilitation of the micturition reflex by bladder irritation. J Urol 1996;155:355-360.
216. Neugebauer V, Rumenapp P, Schaible HG. The role of spinal neurokinin-2 receptors in the processing of nociceptive information from the joint and in the generation and maintenance of inflammation-evoked hyperexcitability of dorsal horn neurons in the rat. Eur J Neurosci 1996;8:249-260.
217. Sakurada T, Sugiyama A, Sakurada C, et al. Effect of spinal nitric oxide inhibition on capsaicin-induced nociceptive response. Life Sci 1996;59:921-930.
218. Cuevas P, Prieto R, Detejada IS, Gimenezgallego G. Analgesic effects of fibroblast growth factor in the rat. Neurosci Lett 1996;207:175-178.
219. Karatinos J, Rosse RB, Deutsch SI. The nitric oxide pathway - potential implications for treatment of neuropsychiatric disorders. Clin Neuropharmacol 1995;18:482-499.
220. Dickenson AH. Central acute pain mechanisms. Ann Med 1995;27:223-227.
221. Shibuta S, Mashimoto T, Ohara A, et al. Intracerebroventricular administration of a nitric oxide-releasing compound, NOC-18, produces thermal hyperalgesia in rats. Neurosci Lett 1995;187:103-106.
222. Gordh T, Karlsten R, Kristensen J. Intervention with spinal NMDA, adenosine, and NO systems for pain modulation. Ann Med 1995;27:229-234.
223. Ren K, Ruda MA. Nitric oxide synthasecontaining neurons in sensory ganglia of the rat are susceptible to capsaicin-induced cytotoxicity. Neuroscience 1995;65:505-511.
224. Rice AS. Topical spinal administration of a nitric oxide synthase inhibitor prevents the hyperreflexia associated with a rat model of persistent visceral pain. Neurosci Lett 1995;187:111-114.
225. Niedbala B, Sanchez A, Feria M. Nitric oxide mediates neuropathic pain behavior in peripherally denervated rats. Neurosci Lett 1995;188:57-60.
226. Morris R, Southam E, Gittins SR, et al. The NO-cGMP pathway in neonatal rat dorsal horn. Eur J Neurosci 1994;6:876-879.
227. Kumar A, Raghubir R, Dhawan BN. Possible involvement of nitric oxide in red nucleus stimulation-induced analgesia in the rat. Eur J Pharmacol 1995;279:1-5.
228. Xu JY, Tseng LF. Nitric oxide/cyclic guanosine monophosphate system in the spinal cord differentially modulates intracerebroventricularly administered morphine-and beta-endorphin-induced antinociception in the mouse. J Pharmacol Exp Ther 1995;274:8-16.
229. Rawal N. Spinal antinociception: clinical aspects. Ann Med 1995;27:263-268.
230. Wiertelak EP, Furness LE, Horan R, et al. Subcutaneous formalin produces centrifugal hyperalgesia at a non-injected site via the NMDA-nitric oxide cascade. Brain Res 1994;649:19-26.
231. Steel JH, Terenghi G, Ghung JM, et al. Increased nitric oxide synthase immunoreactivity in rat dorsal root ganglia in a neuropathic pain model. Neurosci Lett 1994;169:81-84.
232. Dray A. Inflammatory mediators of pain. Br J Anaesth 1995;75:125-131.
233. Palmgren T, Gronblad M, Virri J, et al. Immunohistochemical demonstration of sensory and autonomie nerve terminals in herniated lumbar disc tissue. Spine 1996;21:1301-1306.
234. Oddis CV. New perspectives on osteoarthritis. Am J Med 1996;100:10S-15S.
235. Carotti M, Salaffi F, Ferraccioli GF, et al. Soluble interleukin-2 receptor in sera and synovial fluids of rheumatoid patients: correlations with disease activity. Rheumatol Int 1994;14:47-52.
236. Bull HA, Hothersall J, Chowdhury N, et al. Neuropeptides induce release of nitric oxide from human dermal microvascular endothelial cells. J Invest Dermatol 1996;106:655-660.
237. Kilbourn RG, Fonseca GA, Griffith OW, et al. NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension. Crit Care Med 1995;23:1018-1024.
238. Orucevic A, Lala PK. NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin-2-induced capillary leak syndrome in healthy mice. J Immunother Tumor Immunol 1995;18:210-220.
239. Orucevic A, Lala PK. Effects of N(g)-methyl-L-arginine, an inhibitor of nitric oxide synthesis, on interleukin-2-induced capillary leakage and antitumor responses in healthy and tumor-bearing mice. Cancer Immunol Immunother 1996;42:38-46.
240. Orucevic A, Lala PK. NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumour growth in adenocarcinoma-bearing mice. Br J Cancer 1996;73:189-196.
241. Cifone MG, Festuccia C, Cironi L, et al. Induction of the nitric oxide-synthesizing pathway in fresh and interleukin 2-cultured rat natural killer cells. Cell Immunol 1994;157:181-194.
242. Juretic A, Spagnoli GC, Horig H, et al. Tyrosine kinase-dependent and -independent events induced by interleukin-2 stimulation: interleukin-2-mediated NO production required for the induction of lymphokine-activated killer cell activity in rat splenocytes is tyrosine kinase independent. Immunology 1995;85:325-330.
243. Meller ST, Cummings CP, Traub RJ, Gebhart GF. The role of nitric oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carrageenan in the rat. Neuroscience 1994;60:367-374.
244. Babbedge RG, Wallace P, Gaffen ZA, et al. L-NG-nitro arginine p-nitroanilide (L-NAPNA) is anti-nociceptive in the mouse. Neuroreport 1993;4:307-310.
245. Moore PK, Babbedge RC, Wallace P. et al. 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br J Pharmacol 1993;108:296-297.
246. Babbedge RC, Bland-Ward PA, Hart SL, Moore PK. Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles. Br J Pharmacol 1993;110:225-228.
247. Semba J, Sakai M, Miyoshi R, Kito S. NG-monomethyl-L-arginine, an inhibitor of nitric oxide synthase, increases extracellular GABA in the striatum of the freely moving rat. Neuroreport 1995;6:1426-1428.
248. Kamisaki Y, Wada K, Nakamoto K, Itoh T. Nitric oxide inhibition of the depolarization-evoked glutamate release from synaptosomes of rat cerebellum. Neurosci Lett 1995;194:5-8.
249. Meller ST, Dykstra C, Grzybycki D, et al. The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat. Neuropharmacology 1994;33:1471-1478.
250. Iwamoto ET, Marion L. Pharmacological evidence that nitric oxide mediates the antinociception produced by muscarinic agonists in the rostral ventral medulla of rats. J Pharmacol Exp Ther 1994;269:699-708.
251. Iwamoto ET, Marion L. Pharmacologic evidence that spinal muscarinic analgesia is mediated by an L-arginine/nitric oxide/cyclic GMP cascade in rats. J Pharmacol Exp Ther 1994;271:601-608.
252. Malmberg AB, Yaksh TL. Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain 1993;54:291-300.
253. Bjorkman R. Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paraceta-mol - experimental studies in the rat. Acta Anaesthesiol Scand 1995;39:3-44.
254. Henderson SA, Lee PH, Aeberhard EE, et al. Nitric oxide reduces early growth response-1 gene expression in rat lung macrophages treated with interferon-gamma and lipopolysaccharide. J Biol Chem 1994;269:25239-25242.
255. Ignarro LJ, Aeberhard EE, Henderson SA. Nonsteroidal anti-inflammatory drugs (NSAIDs) prevent transcriptional expression of the inducible NO synthase gene in macrophages by interference with NF-kB activation. In: Moncada S, Stamler J, Gross S, Higgs EA, eds. The biology of nitric oxide, part 5. London: Portland, 1996:5.
256. Aeberhard EE, Henderson SA, Arabolos NS, et al. Nonsteroidal anti-inflammatory drugs inhibit expression of the inducible nitric oxide synthase gene. Biochem Biophys Res Commun 1995;208:1053-1059.
257. Amin AR, Vyas P, Attur M, et al. The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase. Proc Nat Acad Sci USA 1995;92:7926-7930.
258. Xu JY, Tseng LF. Nitric oxide/cyclic guanosine monophosphate system in the spinal cord differentially modulates intracerebroventricularly administered morphine-and beta-endorphin-induced antinociception in the mouse. J Pharmacol Exp Ther 1995;274:8-16.
259. Mao JR, Price DD, Mayer DJ. Experimental mononeuropathy reduces the antinociceptive effects of morphine - implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain 1995;61:353-364.
260. Mao JR, Price DD, Mayer DJ. Mechanisms of hyperalgesia and morphine tolerance - a current view of their possible interactions. Pain 1995;62:259-274.
261. Granadossoto V, Floresmurrieta FJ, Castanedahernandez G, Lopezmunoz FJ. Evidence for the involvement of nitric oxide in the antinociceptive effect of ketorolac. Eur J Pharmacol 1995;277:281-284.
262. Minami T, Onaka M, Okudaashitaka E, et al. L-name, an inhibitor of nitric oxide synthase, blocks the established allodynia induced by intrathecal administration of prostaglandin E(2). Neurosci Lett 1995;201:239-242.
263. Semos ML, Headley PM. The role of nitric oxide in spinal nociceptive reflexes in rats with neurogenic and non-neurogenic peripheral inflammation. Neuropharmacol 1994;33:1487-1497.
264. Holthusen H, Arndt JO. Nitric oxide evokes pain at nociceptors of the paravascular tissue and veins in humans. J Physiol 1995;487:253-258.
265. Kindgenmilles D, Arndt JO. Nitric oxide as a chemical link in the generation of pain from veins in humans. Pain 1996;64:139-142.
266. Kawabata A, Manabe S, Manabe Y, Takagi H. Effect of topical administration of L-arginine on formalin-induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation. Br J Pharmacol 1994;112:547-550.
267. Meyer P, Flammer J, Luscher TF. Local anesthetic drugs reduce endothelium-dependent relaxations of porcine ciliary arteries. Invest Ophthalmol Vis Sci 1993;34:2730-2736.
268. Koltzenburg M, Handwerker HO. Differential ability of human cutaneous nociceptors to signal mechanical pain and to produce vasodilatation. J Neurosci 1994;14(3 Pt 2):1756-1765.
269. Lang E, Claus D, Neundorfer B, Handwerker HO. Parameters of thick and thin nerve-fiber functions as predictors of pain in carpal tunnel syndrome. Pain 1995;60:295-302.
270. Hersch EV, Pertes RA, Ochs HA. Topical capsaicin-pharmacology and potential role in the treatment of temporomandibular pain. J Clin Dent 1994;5:54-59.
271. Handwerker HO. Assessment of the effect of ibuprofen and other non-steroidal anti-rheumatic drugs in experimental algesimetry. Z Rheumatol 1991;50(suppl 1):15-18.
272. Tonussi CR, Ferreira SH. Mechanism of diclofenac analgesia: direct blockade of inflammatory sensitization. Eur J Pharmacol 1994;251:173-179.
273. Aeberhard EE, Henderson SA, Arabolos NS, et al. Nonsteroidal anti-inflammatory drugs inhibit expression of the inducible nitric oxide synthase gene. Biochem Biophys Res Commun 1995;208:1053-1059.
274. Olesen J, Thomsen LL, Lassen LH, Olesen IJ. The nitric oxide hypothesis of migraine and other vascular headaches. Cephalalgia 1995;15:94-100.
275. Thomsen LL, Olesen J. The autonomic nervous system and the regulation of arterial tone in migraine. Clin Autonom Res 1995;5:243-250.
276. Iversen HK, Olesen J. Nitroglycerin-induced headache is not dependent on histamine release: support for a direct nociceptive action of nitric oxide. Cephalalgia 1994;14:437-442.
277. Berrazueta JR, Fleitas M, Salas E, et al. Local transdermal glyceryl trinitrate has an antiinflammatory action on thrombophlebitis induced by sclerosis of leg varicose veins. Angiology 1994;45:347-351.
278. Gorfine SR. Treatment of benign anal disease with topical nitroglycerin. Dis Colon Rectum 1995;38:453-456.
279. Imamura M, Poli F, Omoniyi AT, Levi R. Unmasking of histamine H3 receptorsin myocardial ischemia: their role in as regulators of exocytotic norepinephrine release. J Pharmacol Exp Ther 1994;271:1259-1266.
280. Levi R, Park KH, Imamura M, et al. Nitric oxide and peripheral adrenergic neuromodulation. Adv Pharmacol 1995;34:399-413.
281. de Silva M, Kyle V, Hazleman B, et al. Assessment of inflammation in the rheumatoid knee joint: correlation between clinical, radioisotopic, and thermographic methods. Ann Rheum Dis 1986;45:277-280.
282. Fraser S, Land D, Sturrock RD. Microwave thermography - an index of inflammatory joint disease. Br J Rheumatol 1987;26:37-39.
283. Inoue K, Nishioka J, Kobori T, et al. The use of thermography in the assessment of the rheumatoid knee - the thermographic index and the heat distribution index. Ryumachi 1990;30:356-361.
284. MacDonald AG, Land DV, Sturrock RD. Microwave thermography as a noninvasive assessment of disease activity in inflammatory arthritis. Clin Rheumatol 1994;13:589-592.
285. Ilowite NT, Walco GA, Pochaczevsky R. Assessment of pain in patients with juvenile rheumatoid arthritis: relation between pain intensity and degree of joint inflammation. Ann Rheum Dis 1992;51:343-346.
286. Jolliffe VA, Anand P, Kidd BL. Assessment of cutaneous sensory and autonomic axon reflexes in rheumatoid arthritis. Ann Rheum Dis 1995;54:251-255.
287. Bani D, Masini E, Bello MG, et al. Relaxin activates the L-arginine-nitric oxide pathway in human breast cancer cells. Cancer Res 1995;55:5272-5275.
288. Thomsen LL, Miles DW, Happerfield L, et al. Nitric oxide synthase activity in human breast cancer. Br J Cancer 1995;72:41-44.
289. Spinella M, Bodnar RJ. Nitric oxide synthase inhibition selectively potentiates swim stress antinociception in rats. Pharmacol Biochem Behav 1994;47:727-733.
290. Gold MS, Reichling DB, Shuster MJ, Levine JD. Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors. Proc Nat Acad Sci USA 1996;93:1108-1112.
291. Minami T, Nishihara I, Ito S, et al. Nitric oxide mediates allodynia induced by intrathecal administration of prostaglandin E2 or prostaglandin F2 alpha in conscious mice. Pain 1995;61:285-290.
292. McMahon SB. NGF as a mediator of inflammatory pain. Phil Trans R Soc Lond (Biol) 1996;351:431-440.
293. Peunova N, Enikolopov G. Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature 1995;375:68-73.
294. Pieretti S, Di Giannuario A, Capasso A. et al. Effects induced by cysteamine on chemically-induced nociception in mice. Life Sci 1994;54:1091-1099.
295. Silveri F, Morosini P, Brecciaroli D, Cervini C. Intra-articular injection of somatostatin in knee osteoarthritis: clinical results and IGF-1 serum levels. Int J Clin Pharmacol Res 1994;14:79-85.
296. Taddese A, Nah SY, McCleskey EW. Selective opioid inhibition of small nociceptive neurons. Science 1995;270:1366-1369.
297. Vanhagen PM, Markusse HM, Lamberts SW, et al. Somatostatin receptor imaging. The presence of somatostatin receptors in rheumatoid arthritis. Arthritis Rheum 1994;37:1521-1527.
298. Yin KJ. Distribution of somatostatin mRNA containing neurons in the primary pain relaying nuclei of the rat. Anat Rec 1995;241:579-584.
299. Mirza UA, Chait BT, Lander HM. Monitoring reactions of nitric oxide with peptides and proteins by electrospray ionization-mass spectrometry. J Biol Chem 1995;270:17185-17188.
300. Bscheidl C, Hanesch U, Heppelmann B. NADPH-diaphorase reactivity in articular afferents of a normal and inflamed knee joint in the cat. Brain Res 1994;668:266-270.
301. Cramer KS, Sur M. Activity-dependent remodeling of connections in the mammalian visual system. Curr Opin Neurobiol 1995;5:106-111.
302. Doyle C, Holscher C, Rowan MJ, Anwyl R. The selective neuronal NO synthase inhibitor 7-nitro-indazole blocks both long-term potentiation and depotentiation of field EPSPs in rat hippocampal CA1 in vivo. J Neurosci 1996;16:418-424.
303. Gupta S, Moreland RB, Munarriz R, et al. Possible role of Na+-K+-ATPase in the regulation of human corpus cavernosum smooth muscle contractility by nitric oxide. Br J Pharmacol 1995;116:2201-2206.
304. Kurenny DE, Moroz LL, Turner RW, et al. Modulation of ion channels in rod photoreceptors by nitric oxide. Neuron 1994;13:315-324.
305. Ahmad I, Leinders-Zufall T, Kocsis JD, et al. Retinal ganglion cells express a cGMP-gated cation conductance activatable by nitric oxide donors. Neuron 1994;12:155-165.
306. Akira T, Henry D, Baldwin RA, Wasterlain CG. Nitric oxide participates in excitotoxic mechanisms induced by chemical hypoxia. Brain Res 1994;645:285-290.
307. Kolhekar R, Meller ST, Gebhart GF. N-methyl-D-aspartate receptor-mediated changes in thermal nociception - allosteric modulation at glycine and polyamine recognition sites. Neuroscience 1994;63:925-936.
308. Ding JM, Chen D, Weber ET, et al. Resetting the biological clock: mediation of nocturnal circadian shifts by glutamate and NO. Science 1994;266:1713-1717.
309. Masutani H, Nagai K, Nakagawa H. Possible involvement of nitric oxide in generation of circadian rhythm. Biol Rhythm Res 1994;25:433-441.
310. Watanabe A, Hamada T, Shibata S, Watanabe S. Effects of nitric oxide synthase inhibitors on N-methyl-D-aspartate-induced phase delay of circadian rhythm of neuronal activity in the rat suprachiasmatic nucleus in vitro. Brain Res 1994;646:161-164.
311. Linderoth B, Fedorcsak I, Meyerson BA. Peripheral vasodilatation after spinal cord stimulation: animal studies of putative effector mechanisms. Neurosurgery 1991;28:187-195.
312. Olgart L, Kerezoudis NP. Nerve-pulp interactions. Arch Oral Biol 1994;39(suppl):47S-54S.
313. Linderoth B, Herregodts P, Meyerson BA. Sympathetic mediation of peripheral vasodilation induced by spinal cord stimulation: animal studies of the role of cholinergic and adrenergic receptor subtypes. Neurosurgery 1994;35:711-719.
314. Wiertelak EP, Furness LE, Watkins LR, Maier SF. Illness-induced hyperalgesia is mediated by a spinal NMDA-nitric oxide cascade. Brain Res 1994;664:9-16.
315. Dickenson AH. Central acute pain mechanisms. Ann Med 1995;27:223-227.
316. Meller ST, Gebhart GF. The role of nitric oxide in spinal nociceptive processing. In: Takagi H, Toda N, Hawkins RD, eds. Nitric oxide: role in neuronal communication and neurotoxicity. Tokyo: Japan Scientific Societies Press and CRC Press, 1994:103-114.
317. Kawabata A, Takagi H. The dual role of L-arginine in nociceptive processing in the brain: Involvement of nitric oxide and kyotorphin. In: Takagi H, Toda N, Hawkins RD, eds. Nitric oxide: role in neuronal communication and neurotoxicity. Tokyo: Japan Scientific Societies Press and CRC Press, 1994:115-128.
318. Jones AK, Cunningham VJ, Ha-Kawa S, et al. Changes in central opioid receptor binding in relation to inflammation and pain in patients with rheumatoid arthritis. Br J Rheumatol 1994;33:909-916.
319. Turnbull AV, Rivier C. Corticotropin-releasing factor, vasopressin, and prostaglandins mediate, and nitric oxide restrains, the hypothalamic-pituitary-adrenal response to acute local inflammation in the rat. Endocrinology 1996;137:455-463.
320. Denucci DJ, Dionne RA, Dubner R. Identifying a neurobiologic basis for drug therapy in TMDs. J Am Dent Assoc 1996;127:581-593.
321. Crosby G, Marota JJA, Huang PL. Intact nociception-induced neuroplasticity in transgenic mice deficient in neuronal nitric oxide synthase. Neuroscience 1995;69:1013-1017.
322. Wong ML, Rettori V, al-Shekhlee A, et al. Inducible nitric oxide synthase gene expression in the brain during systemic inflammation. Nature Med 1996;2:581-584.
323. Morris R, Southam E, Gittins SR, Garthwaite J. NADPH-diaphorase staining in autonomic and somatic cranial ganglia of the rat. Neuroreport 1993;4:62-64.
324. Shetty V, Gratt BM, Flack V. Thermographic assessment of reversible inferior alveolar nerve deficit. J. Orofacial Pain 1994;8:375-383.
325. Babey AM, Kolesnikov Y, Cheng J, et al. Nitric oxide and opioid tolerance. Neuropharmacology 1994;33:1463-1470.
326. Brignola G, Calignano A, Di Rosa M. Modulation of morphine antinociception in the mouse by endogenous nitric oxide. Br J Pharmacol 1994;113:1372-1376.
327. Az-ma TH, Hardian A, Yugo O. Inhibitory effect of lidocaine on cultured porcine aortic endothelial cell-dependent antiaggregation of platelets. Anesthesiology 1995;83:374-381.
328. Farhat MY, Lavigne MC, Ramwell PW. The vascular protective effects of estrogen. FASEB J 1996;10:615-624.
329. Hishikawa K, Nakaki T, Marumo T, et al. Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett 1995;360:291-293.
330. Hayashi T, Yamada K, Esaki T, et al. Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophy Res Commun 1995;214:847-855.
331. Mendelsohn ME, Karas RH. Estrogen and the blood vessel wall. Curr Opin Cardiol 1994;9:619-626.
332. Veille JC, Li P, Eisenach JC, et al. Effects of estrogen on nitric oxide biosynthesis and vasorelaxant activity in sheep uterine and renal arteries in vitro. Am J Obstet Gynecol 1996;174:1043-1049.
333. Gorodeski GI, Yang T, Levy MN, et al. Effects of estrogen in vivo on coronary vascular resistance in perfused rabbit hearts. Am J Physiol 1995;269(6 Pt 2):R1333-R1338.
334. Figueroa JP, Massmann GA. Estrogen increases nitric oxide synthase activity in the uterus of nonpregnant sheep. Am J Obstet Gynecol 1995;173:1539-1545.
335. Miller VM, Vanhoutte PM. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am J Physiol 1991;261:R1022-R1027.
336. Miller L, Alley EW, Murphy WJ, et al. Progesterone inhibits inducible nitric oxide synthase gene expression and nitric oxide production in murine macrophages. J Leukoc Biol 1996;59:442-450.
337. Rosselli M, Imthurm B, Macas E, et al. Circulating nitrite/nitrate levels increase with follicular development, indirect evidence for estradiol mediated NO release. Biochem Biophys Res Commun 1994;202:1543-1552.
338. Weiner CP, Knowles RG, Moncada S. Induction of nitric oxide synthases early in pregnancy. Am J Obstet Gynecol 1994;171:838-843.
339. Goetz RM, Morano I, Calovini T, et al. Increased expression of endothelial constitutive nitric oxide synthase in rat aorta during pregnancy. Biochem Biophys Res Commun 1994;205:905-910.
340. Collins P, Shay J, Jiang C, Moss J. Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal. Circulation 1994;90:1964-1968.
341. Weiner CP, Lizasoain I, Baylis SA, et al. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 1994;91:5212-5216.
342. Hayashi T, Ishikawa T, Yamada K, et al. Biphasic effect of estrogen on neuronal constitutive nitric oxide synthase via Ca(2+)-calmodulin dependent mechanism. Biochem Biophys Res Commun 1994;203:1013-1019.
343. Lizasoain I, Weiner CP, Knowles RG, Moncada S. The ontogeny of cerebral and cerebellar nitric oxide synthase in the guinea pig and rat. Pediatr Res 1996;39:779-783.
344. Pu SY, Xu B, Kalra SP, Kalra PS. Evidence that gonadal steroids modulate nitric oxide efflux in the medial preoptic area - effects of N-methyl-D-aspartate and correlation with luteinizing hormone secretion. Endocrinology 1996;137:1949-1955.
345. Mogil JS, Sternberg WF, Kest B, et al. Sex differences in the antagonism of swim stress-induced analgesia: effects of gonadectomy and estrogen replacement. Pain 1993;53:17-25.
346. Szabo C, Thiemermann C, Wu CC, et al. Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc Natl Acad Sci USA 1994;91:271-275.
347. Bonello N, McKie K, Jasper M, et al. Inhibition of nitric oxide: effects on interleukin-1 beta-enhanced ovulation rate, steroid hormones, and ovarian leukocyte distribution at ovulation in the rat. Biol Reprod 1996;54:436-445.
348. Imalawansa SJ, De Marco G, Gangula P, Yallampalli C. Nitric oxide donor alleviates ovariectomy-induced bone loss. Bone 1996;18:301-304.
349. Miller-Blair DJ, Robbins DL. Rheumatoid arthritis: new science, new treatment. Geriatrics 1993;48:28-31, 35-38.
350. Jackel WH, Gerdes N, Cziske R, Jacobi E. Epidemiology of rheumatic complaints in Germany. Data on the prevalence and physical and psychosocial disability. Z Rheumatol 1993;52:281-288.
351. Da Silva JA, Hall GM. The effects of gender and sex hormones on outcome in rheumatoid arthritis. Baillieres Clin Rheumatol 1992;6:196-219.
352. Abubaker AO, Raslan WF, Sotereanos GC. Estrogen and progesterone receptors in temporomandibular joint discs of symptomatic and asymptomatic persons: a preliminary study. J Oral Maxillofac Surg 1993;51:1096-1100.
353. Campbell JH, Courey MS, Bourne P, Odziemiec C. Estrogen receptor analysis of human temporomandibular disc. J Oral Maxillofac Surg 1993;51:1101-1105.
354. Anbar M. The role of nitric oxide in the evolution of living systems from premordial prokaryotes to eukaryotes - a hypothesis. In: Moncada S, Stamler J, Gross S, Higgs EA, eds. The biology of nitric oxide, part 5. London: Portland Press, 1996:226a-226d.
355. Obi T, Kabeyama A, Nishio A. Equine coronary artery responds to 5-hydroxytryptamine with relaxation in vitro. J Vet Pharmacol Ther 1994;17:218-225.
356. Akiho H, Chijiiwa Y, Okabe H, et al. Direct inhibitory effect of atrial natriuretic peptide on isolated caecal circular smooth muscle cells via soluble guanylate cyclase. Life Sci 1994;55:1293-1299.
357. Chiang LW, Schweizer FE, Tsien RW, Schulman H. Nitric oxide synthase expression in single hippocampal neurons. Mol Brain Res 1994;27:183-188.
358. Watanabe Y, Saito H, Abe K. Nitric oxide is involved in long-term potentiation in the medial but not lateral amygdala neuron synapses in vitro. Brain Res 1995;688:233-236.
359. Hawkins RD, Zhuo M, Arancio O. Nitric oxide and carbon monoxide as possible retograde messengers in hippocampal long-term potentiation. In: Takagi H, Toda N, Hawkins RD, eds. Nitric oxide: role in neuronal communication and neurotoxicity. xxx: Japan Scientific Societies Press and CRC Press, 1994:129-148.
360. Abe K, Mizutani A, Saito H. Possible role of nitric oxide in long-term potentiation in the dentate gyrus. In: Takagi H, Toda N, Hawkins RD, eds. Nitric oxide: role in neuronal communication and neurotoxicity. xxx: Japan Scientific Societies Press and CRC Press, 1994:149-160.
361. Dawson TM, Dawson VL, Snyder SH. Molecular mechanisms of nitric oxide actions in the brain. Ann NY Acad Sci 1994;738:76-85.
362. Schulz JB, Matthews RT, Muqit MM, et al. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J Neurochem 1995;64:936-939.
363. O'Dell TJ, Huang PL, Dawson TM, et al. Endothelial NOS and the blockade of LTP by NOS inhibitors in mice lacking neuronal NOS. Science 1994;265:542-546.
364. Kosaka H, Seiyama A. Physiological role of nitric oxide as an enhancer of oxygen transfer from erythrocytes to tissues. Biochem Biophys Res Commun 1996;218:749-752.
365. Goode HF, Howdle PD, Walker BE, Webster NR. Nitric oxide synthase activity is increased in patients with sepsis syndrome. Clin Sci 1995;88:131-133.
366. Tsuneyoshi I, Kanmura Y, Yoshimura N. Nitric oxide as a mediator of reduced arterial responsiveness in septic patients. Crit Care Med 1996;24:1083-1086.
367. Doughty LA, Kaplan SS, Carcillo JA. Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure. Crit Care Med 1996;24:1137-1143.
368. Herbertson MJ, Werner HA, Walley KR. Nitric oxide synthase inhibition partially prevents decreased LV contractility during endotoxemia. Am J Physiol 1996;270:H1979-H1984.
369. Harbrecht BG, Wang SC, Simmons RL, Billiar TR. Cyclic gmp and guanylate cyclase mediate lipopolysaccharide-induced kupffer cell tumor necrosis factor-alpha synthesis. J Leukoc Biol 1995;57:297-302.
370. Neilly IJ, Copland M, Haj M, Adey G, et al. Plasma nitrate concentrations in neutropenic and non-neutropenic patients with suspected septicaemia. Br J Haematol 1995;89:199-202.
371. Wong HR, Carcillo JA, Burckart G, Kaplan SS. Nitric oxide production in critically ill patients. Arch Dis Child 1996;74:482-489.
372. Fukatsu K, Saito H, Fukushima R, et al. Effects of three inhibitors of nitric oxide synthase on host resistance to bacterial infection. Inflam Res 1996;45:109-112.
373. Villa P, Sartor G, Angelini M, et al. Pattern of cytokines and pharmacomodulation in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin. Clin Diagnos Lab Immunol 1995;2:549-553.
374. Moffat FL Jr, Han T, Li ZM, et al. Supplemental L-arginine HC1 augments bacterial phagocytosis in human polymorphonuclear leukocytes. J Cell Physiol 1996;168:26-33.
375. Collins KJ. The autonomic nervous system and the regulation of body temperature. In: Bannister R, Mathias CJ, eds. Autonomic failure, 3rd ed. New York: Oxford University Press, 1993:212-230.
376. Freeman G, Dyer RL, Juhos L, et al. Identifica-tion of nitric oxide (NO) in human blood. Arch Environ Health 1978;33:19-23.
377. Maeda N, Imaizumi K, Kon K, Shiga T. A kinetic study on functional impairment of nitric oxide-exposed rat erythrocytes. Environ Health Perspect 1987;73:171-177.
378. Sampath V, Zhao XJ, Caughey WS. Characterization of interactions of nitric oxide with human hemoglobin A by infrared spectroscopy. Biochem Biophys Res Commun 1994;198:281-287.
379. Eriksson LE. Binding of nitric oxide to intact human erythrocytes as monitored by electron paramagnetic resonance. Biochem Biophys Res Commun 1994;203:176-181.
380. Eich RF, Li T, Lemon DD, et al. Mechanism of NO-induced oxidation of myoglobin and hemoglobin. Biochemistry 1996;35:6976-6983.
381. Feelisch M, Kubitzek D, Werringloer J. The oxyhemoglobin assay. In: Feelisch M, Stamler JS, eds. Methods in nitric oxide research. Chichester: John Wiley and Sons, 1996:455-478.
382. Radomski MW, Palmer RM, Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 1990;87:5193-5197.
383. Bode-Boger SM, Boger RH, Creutzig A, et al. L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. Clin Sci 1994;87:303-310.
384. Anbar M. Quantitive dynamic telethermometry in medical diagnosis and management. Boca Raton: CRC Press, 1994.
385. Anbar M, Montoro JC, Lee K-H, D'Arcy S. Manifestation of neurological abnormalities through frequency analysis of skin temperature regulation. Thermology 1991;3:234-241.
386. Chinzei T, Saito I, Ikeda M, et al. Thermalrhythm imaging of skin temperature with a highspeed thermal camera. Biomed Thermol 1995;15:150-152.
387. Anbar M, Grenn MW, Marino MT, et al. Fast dynamic area telethermometry (DAT) of the human forearm with a Ga/As quantum well infrared focal plane array camera. Thermologie Osterreich 1997;7:105-118.
388. Chen AC, Rappelsberger P. Brain and human pain: topographic EEG amplitude and coherence mapping. Brain Topogr 1994;7:129-140.
389. Ferracuti S, Seri S, Mattia D, Cruccu G. Quantitative EEG modifications during the cold water pressor test: hemispheric and hand differences. Int J Psychophysiol 1994;17:261-268.
390. Sanders SP, Zweier JL, Kuppusamy P, et al. Hyperoxic sheep pulmonary microvascular endothelial cells generate free radicals via mitochondrial electron transport. T Clin Invest 1993;91:46-52.
391. Lindau-Shepard B, Shaffer JB, Del Vecchio PJ. Overexpression of manganous superoxide dismutase (MnSOD) in pulmonary endothelial cells confers resistance to hyperoxia. J Cell Physiol 1994;161:237-242.
392. Gardner PR, Nguyen DD, White CW. Aconitase is a sensitive and critical target of oxygen poisoning in cultured mammalian cells and in rat lungs. Proc Natl Acad Sci USA 1994;91:12248-12252.
393. Gardner PR, Raineri I, Epstein LB, White CW. Superoxide radical and iron modulate aconitase activity in mammalian cells. J Biol Chem 1995;270:13399-13405.
394. Kong XJ, Lee SL, Lanzillo JJ, Fanburg BL. Cu,Zn superoxide dismutase in vascular cells: changes during cell cycling and exposure to hyperoxia. Am J Physiol 1993;264:L365-L375.
395. Quinlan T, Spivack S, Mossman BT. Regulation of antioxidant enzymes in lung after oxidant injury. Environ Health Perspect 1994;102(suppl 2):79-87.
396. Lee CY, Pastore JN, Tang G, Tsan MF. Cellular distribution of pulmonary Mn and CuZn superoxide dismutase: effect of hyperoxia and interleukin-1. J Histochem Cytochem 1994;42:1201-1205.
397. Mikawa K, Nishina K, Maekawa N, Obara H. Attenuation of hyperoxic lung injury in rabbits with superoxide dismutase - effects on inflammatory mediators. Acta Anaesthesiol Scand 1995;39:317-322.
398. Karadsheh NS, Khraisha S. Comparative study of the levels of antioxidants of students at Amman and Dead Sea level. Aviat Space Environ Med 1993;64:1125-1127.
399. Beckmann JS, Ye YZ, Anderson PG, et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler 1994;375:81-88.
400. Squadrito GL, Pryor WA. The formation of peroxynitrite in vivo from nitric oxide and superoxide. Chem Biol Interact 1995;96:203-206.
401. Anbar M. Mechanism of hyperthermia of the cancerous breast. Biomed Thermol 1995;15:135-139.
402. Burkart V, Gross-Eick A, Bellmann K, et al. Suppression of nitric oxide toxicity in islet cells by alpha-tocopherol. FEBS Lett 1995;364:259-263.
403. Lee YS, Wurster RD. Potentiation of antiproliferative effect of nitroprusside by ascorbate in human brain tumor cells. Cancer Lett 1994;78:19-23.
404. Mannick EE, Bravo LE, Zarama G, et al. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res 1996;56:3238-3243.
405. Satarug S, Haswellelkins MR, Tsuda M, et al. Thiocyanate-independent nitrosation in humans with carcinogenic parasite infection. Carcinogenesis 1996;17:1075-1081.
406. DeFeudis FV. Excess EDRF/NO, a potentially deleterious condition that may be involved in accelerated atherogenesis and other chronic disease states. Gen Pharmacol 1995;26:667-680.
407. Ghosh SK, Ekpo EB, Shah IU, et al. A double-blind, placebo-controlled parallel trial of vitamin C treatment in elderly patients with hypertension. Gerontology 1994;40:268-272.
408. Toohey L, Harris MA, Allen KG, Melby CL. Plasma ascorbic acid concentrations are related to cardiovascular risk factors in African-Americans. J Nutr 1996;126:121-128.
409. Bendich A, Langseth L. The health effects of vitamin C supplementation: a review. J Am Coll Nutr 1995;14:124-136.
410. Ness AR, Khaw KT, Bingham S, Day NE. Vitamin C status and blood pressure. J Hypertens 1996;14:503-508.
411. Faucett J, Gordon N, Levine J. Differences in postoperative pain severity among four ethnic groups. J Pain Symptom Manage 1994;9:383-389.
412. Graff-Radford SB, Ketalaer M-C, Gratt BM, Solberg WK. Thermographic assessment of neuropathic facial pain. J Orofacial Pain 1995;9:138-146.
413. Canavan D, Graff-Radford SB, Gratt BM. Traumatic dysesthesia of the trigerninal nerve. J Orofacial Pain 1994;8:391-396.
414. Bush FM, Harkins SW, Harrington WG, Price DD. Analysis of gender effects on pain perception and symptom presentation in temporomandibular pain. Pain 1993;53:73-80.
415. Allerbring M, Haegerstam G. Invasive dental treatment, pain reports, and disease conviction in chronic facial pain patients. A retrospective study. Acta Odontol Scand 1995;53:41-43.
416. Wallace JL, Reuter BK, Cirino G. Nitric oxide-releasing non-steroidal anti-inflammatory drugs - a novel approach for reducing gastrointestinal toxicity. J Gastroenterol Hepatol 1994;9:S40-S44.
417. Weisenberg M, Tepper I, Schwarzwald J. Humor as a cognitive technique for increasing pain tolerance. Pain 1995;63:207-212.
418. Syrjala KL, Donaldson GW, Davis MW, et al. Relaxation and imagery and cognitive-behavioral training reduce pain during cancer treatment - a controlled clinical trial. Pain 1995;63:189-198.